Pyrexia, commonly referred to as fever, is a frequent symptom encountered in clinical practice. It is an increase in body temperature as a response to pathogenic invasion or inflammation. Understanding the underlying mechanisms and effective management strategies is crucial for healthcare professionals.
Pyrexia is primarily triggered by pyrogens, which can be either exogenous, such as bacterial toxins, or endogenous, like cytokines. These substances instigate the hypothalamus to elevate the body's thermoregulatory set-point, leading to fever. It is a defense mechanism, aiming to create an unfavorable environment for pathogens.
A comprehensive history and physical examination form the cornerstone of assessing a febrile patient. The duration, pattern, and associated symptoms of fever can provide valuable clues to the underlying cause. Laboratory tests and imaging studies can be utilized based on clinical suspicion.
Management of pyrexia involves treating the underlying cause and symptomatic relief. Antipyretics such as paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used. Care should be taken with the elderly, infants, and immunocompromised patients, as fever can have deleterious effects in these populations.
While antipyretics are effective in reducing discomfort, their use should be judicious. Fever is a physiological response and its suppression may potentially hamper the body's defense mechanism. Therefore, the decision to use antipyretics should be individualized, considering the patient's condition and comfort.
Pyrexia is a common clinical presentation with a wide array of underlying causes. A thorough understanding of its pathophysiology, assessment, and management strategies is essential for optimal patient care. While antipyretics provide symptomatic relief, their use should be balanced with the potential impact on the body's defense mechanisms.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation